Drugs combination 'could create effective anti-kidney cancer weapon'

Drugs combination 'could create effective anti-kidney cancer weapon'
 

Scientists found that 40% of patients treated with nivolumab and ipilimumab experienced a significant reduction in the size of their tumours.
In a tenth of these patients the cancer appeared to have vanished. There was no detectable sign of disease.
The CheckMate -016 study was an early Phase I trial chiefly designed to investigate doses and side effects.
Dr Hans Hammers, from the University of Texas Southwestern Medical Centre in the US, said: "There remains a significant unmet need for treatment options that offer ongoing responses and increase survival for patients with renal cell... read more

 
9 October 2016 in Regional West, Views: 47
Share:
 




News Widget for Webmasters


Realtime News

 

«
»
Mo Tu We Th Fr Sa Su
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31